| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |